Swiss National Bank Sarepta Therapeutics, Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 166,083 shares of SRPT stock, worth $19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
166,083
Previous 166,083 -0.0%
Holding current value
$19 Million
Previous $26.2 Million 20.95%
% of portfolio
0.01%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$113.33 - $163.85 $11,333 - $16,385
-100 Reduced 0.06%
166,083 $26.2 Million
Q1 2024

May 07, 2024
BUY
$93.7 - $141.53 $927,630 - $1.4 Million
9,900 Added 6.33%
166,183 $21.5 Million
Q4 2023

Feb 06, 2024
SELL
$67.31 - $124.76 $1.2 Million - $2.22 Million
-17,800 Reduced 10.23%
156,283 $15.1 Million
Q3 2023

Nov 08, 2023
BUY
$102.5 - $123.59 $1.16 Million - $1.4 Million
11,300 Added 6.94%
174,083 $21.1 Million
Q2 2023

Aug 09, 2023
SELL
$106.4 - $157.19 $821,088 - $1.21 Million
-7,717 Reduced 4.53%
162,783 $18.6 Million
Q1 2023

May 10, 2023
SELL
$117.53 - $155.99 $2.33 Million - $3.09 Million
-19,800 Reduced 10.4%
170,500 $23.5 Million
Q4 2022

Feb 08, 2023
SELL
$100.86 - $132.13 $685,848 - $898,484
-6,800 Reduced 3.45%
190,300 $24.7 Million
Q3 2022

Nov 09, 2022
BUY
$75.71 - $119.24 $166,562 - $262,328
2,200 Added 1.13%
197,100 $21.8 Million
Q2 2022

Aug 09, 2022
SELL
$62.69 - $88.44 $43,883 - $61,908
-700 Reduced 0.36%
194,900 $14.6 Million
Q1 2022

May 09, 2022
BUY
$63.15 - $90.42 $1.81 Million - $2.59 Million
28,600 Added 17.13%
195,600 $15.3 Million
Q4 2021

Feb 08, 2022
SELL
$77.28 - $99.42 $30,912 - $39,768
-400 Reduced 0.24%
167,000 $15 Million
Q3 2021

Nov 08, 2021
BUY
$65.97 - $92.48 $52,776 - $73,984
800 Added 0.48%
167,400 $15.5 Million
Q2 2021

Aug 06, 2021
SELL
$69.38 - $86.75 $8.37 Million - $10.5 Million
-120,573 Reduced 41.99%
166,600 $13 Million
Q1 2021

May 07, 2021
BUY
$72.25 - $168.95 $419,050 - $979,909
5,800 Added 2.06%
287,173 $21.4 Million
Q4 2020

Feb 05, 2021
SELL
$125.56 - $178.74 $866,364 - $1.23 Million
-6,900 Reduced 2.39%
281,373 $48 Million
Q3 2020

Nov 09, 2020
SELL
$127.12 - $172.34 $508,480 - $689,360
-4,000 Reduced 1.37%
288,273 $40.5 Million
Q2 2020

Aug 05, 2020
BUY
$93.0 - $171.7 $269,700 - $497,929
2,900 Added 1.0%
292,273 $46.9 Million
Q1 2020

May 08, 2020
BUY
$82.38 - $131.64 $4.53 Million - $7.24 Million
55,000 Added 23.47%
289,373 $28.3 Million
Q4 2019

Feb 06, 2020
SELL
$76.53 - $135.58 $742,341 - $1.32 Million
-9,700 Reduced 3.97%
234,373 $30.2 Million
Q3 2019

Nov 12, 2019
BUY
$72.81 - $156.91 $8.6 Million - $18.5 Million
118,073 Added 93.71%
244,073 $18.4 Million
Q2 2019

Aug 02, 2019
BUY
$112.21 - $151.95 $437,619 - $592,605
3,900 Added 3.19%
126,000 $19.1 Million
Q1 2019

May 10, 2019
BUY
$106.67 - $151.68 $1.12 Million - $1.59 Million
10,500 Added 9.41%
122,100 $14.6 Million
Q4 2018

Feb 13, 2019
BUY
$97.32 - $148.76 $291,960 - $446,280
3,000 Added 2.76%
111,600 $12.2 Million
Q3 2018

Nov 08, 2018
BUY
$115.31 - $161.51 $242,151 - $339,171
2,100 Added 1.97%
108,600 $17.5 Million
Q1 2018

May 04, 2018
BUY
$54.02 - $82.27 $129,648 - $197,448
2,400 Added 2.31%
106,500 $7.89 Million
Q4 2017

Feb 07, 2018
BUY
$47.64 - $56.75 $223,908 - $266,725
4,700 Added 4.73%
104,100 $5.79 Million
Q3 2017

Nov 03, 2017
BUY
$35.73 - $47.15 $3.55 Million - $4.69 Million
99,400
99,400 $4.51 Million

Others Institutions Holding SRPT

# of Institutions
530
Shares Held
84.5M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email